<DOC>
	<DOCNO>NCT01174719</DOCNO>
	<brief_summary>The aim study compare three different regimen volume replacement cardiac surgery , e.g . Albumin 5 % , Hydroxyethylstarch 130/0.4 ( HES ) Ringer-Lactate ( RL ) . Main Outcome parameter : chest tube drainage coagulation parameter . The investigator hypothesis HES safe Albumin , however less expensive . Whether RL even less expensive safe alternative show .</brief_summary>
	<brief_title>Humanalbumin , Hydroxyethylstarch Ringer Lactate During Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>Valve replacement Coronary bypass surgery Severe leave ventricular dysfunction Coagulation disorder</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Hydroxyethylstarch</keyword>
	<keyword>Humanalbumin</keyword>
	<keyword>Ringer Lactate</keyword>
	<keyword>patient undergo cardiac surgery</keyword>
</DOC>